Strs Ohio Sells 9,232 Shares of Cigna Group $CI

Strs Ohio decreased its position in shares of Cigna Group (NYSE:CIFree Report) by 12.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 62,105 shares of the health services provider’s stock after selling 9,232 shares during the period. Strs Ohio’s holdings in Cigna Group were worth $17,902,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in CI. Solstein Capital LLC bought a new position in shares of Cigna Group in the 2nd quarter valued at $29,000. Harbor Capital Advisors Inc. boosted its stake in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after buying an additional 49 shares in the last quarter. Chilton Capital Management LLC acquired a new stake in Cigna Group in the second quarter valued at about $30,000. Princeton Global Asset Management LLC grew its position in Cigna Group by 115.6% in the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 52 shares during the last quarter. Finally, Quaker Wealth Management LLC raised its stake in Cigna Group by 201.0% during the second quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock worth $35,000 after acquiring an additional 211 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CI has been the topic of a number of research analyst reports. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Guggenheim restated a “buy” rating and issued a $318.00 target price on shares of Cigna Group in a research report on Tuesday, December 2nd. The Goldman Sachs Group decreased their target price on shares of Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research note on Tuesday, November 4th. Jefferies Financial Group reiterated a “buy” rating and issued a $310.00 price target on shares of Cigna Group in a research note on Monday, November 3rd. Finally, Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $330.36.

Check Out Our Latest Analysis on CI

Insider Activity

In related news, CEO David Cordani acquired 4,134 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. 0.70% of the stock is owned by company insiders.

Cigna Group Price Performance

CI stock opened at $279.31 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a market capitalization of $74.61 billion, a P/E ratio of 12.32, a PEG ratio of 0.98 and a beta of 0.26. The company has a fifty day moving average price of $274.46 and a 200-day moving average price of $285.63.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.Cigna Group’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period in the prior year, the business posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.